Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-13-010689
Filing Date
2013-03-05
Accepted
2013-03-05 16:23:06
Documents
1
Period of Report
2013-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 7421
  Complete submission text file 0001140361-13-010689.txt   8854
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address
Soni Rakesh (Reporting) CIK: 0001440181 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34079 | Film No.: 13665984